(Q46813406)

25 December 2017

title

Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging? (English)

1 reference

25 December 2017

1 reference

Marcus Baumann

1

1 reference

25 December 2017

Roger Bartholome

2

1 reference

25 December 2017

Carine J Peutz-Kootstra

3

1 reference

25 December 2017

Jos F M Smits

4

1 reference

25 December 2017

Harry A J Struijker-Boudier

5

1 reference

25 December 2017

publication date

10 January 2008

1 reference

25 December 2017

Journal of Clinical Hypertension

published in

1 reference

25 December 2017

volume

21

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

177-182

1 reference

25 December 2017

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Telomeres: the time factor in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Workshop: excess growth and apoptosis: is hypertension a case of accelerated aging of cardiovascular cells?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Telomere length inversely correlates with pulse pressure and is highly familial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Evidence of an altered in vivo vascular cell turnover in spontaneously hypertensive rats and its modulation by long-term antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Apoptosis in target organs of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Apoptosis in the muscular arteries from young spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Different cell cycle regulation of vascular smooth muscle in genetic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Expression of cell cycle proteins in blood vessels of angiotensin II-infused rats: role of AT(1) receptors

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Protective effect of the inhibition of the renin-angiotensin system on aging

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Telomere measurement by quantitative PCR

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Telomeres and cardiovascular disease: does size matter?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

The renin-angiotensin system and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Mineralocorticoids, hypertension, and cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats into the S phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Reflections on telomeres, growth, aging, and essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Feasibility of treating prehypertension with an angiotensin-receptor blocker

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.30

7 January 2021

Identifiers

DOI

10.1038/AJH.2007.30

1 reference

25 December 2017

1 reference

25 December 2017